followers 0 popularity
2
following 1

following  view all

Groups
mansi123 is not in any groups
mansi123

China Inhaler Market Size, Share, Trends & Forecast 2019-2025.

Feb 18th 2020 at 2:11 AM

China inhaler market was valued at around $2.2 billion in 2018 and is anticipated to grow at a substantial rate of 3.3% during the forecast period. High level of air pollution and significant number of smokers in China is boosting the demand for inhalers in the country. Additionally, rising geriatric population susceptible to asthma and COPD within the country is also driving the demand for inhalers. During June 2012 to May 2015, a survey was conducted by the Ministry of Health and Ministry of Science and Technology of China. About 51,000 citizens participated in the survey with 21,500 men and 29,500 women, according to which, it was estimated that about 100 million adults in 2015 had problem of COPD in the country. The prevalence is higher in men as compared to women. As per the estimation, there were 68.4 million men and 31.5 million women affected by COPD.

Request a Free Sample of our Report China Inhaler Markethttps://www.omrglobal.com/request-sample/china-inhaler-market

The China inhaler market is segmented on the basis of device, type, application, and end-user. On the basis of device, the market is sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer. The dry powder inhaler is estimated to have largest market share in the China inhaler market due to providing easy inhalation solution. Whereas, the market for metered dose inhaler is estimated to be the fastest growing at a CAGR during the forecast period owing to innovations and collaborations by the companies for the development of metered dosed inhaler. Based on the type, preventive, reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

A full Report of China Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/china-inhaler-market

China Inhaler Market Segmentation

By Device

  • Metered Dose Inhaler
  • Dry Powder Inhaler
  • Nebulizer

By Type

  • Preventive Inhaler
  • Reliever Inhaler
  • Long Acting Bronchodilators Inhaler

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

By End-User

  • Homecare
  • Hospitals and Clinics

Company Profiles

  • 3M Co.
  • Adherium Ltd.
  • Aradigm Corp.
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Gerresheimer AG
  • GlaxoSmithKline PLC
  • Koninklijke Philips N.V.
  • Novartis AG
  • ResMed Corp.
  • Sunovion Pharmaceuticals
  • Teva Pharmaceuticals Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-inhaler-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 7803040404

0 comments
Please to comment

sign in

Username
Password
Remember Me


New to IM faceplate? join free!

Lost Password? click here